MarketPeel
Insider Trading Intelligence
RM

Rachel Mcminn

NGNE
CHIEF EXECUTIVE OFFICER · NEUROGENE INC. · CIK 0001606302
FILING MIX · LIFETIME86%/14%
BUYS
6
SELLS
1
TOTAL VALUE
$1.04M
COMPANIES
1
ACTIVE SINCE
Mar 2024
HOLDINGS NOW
1,344,307
AVG SELL PX
$22.07
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Rachel Mcminn, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+10.95%+1.42%+9.53%+9.53%
14d2+100.00%+8.33%+3.73%+4.60%+4.60%
30d2+50.00%+18.54%+5.44%+13.11%+13.11%
60d2+0.00%+5.65%+1.61%-19.73%-19.73%
90d2+0.00%+16.27%+8.28%+7.99%+7.99%
180d2(1 pending)+0.00%-13.84%-1.50%-12.34%-12.34%
1y2(1 pending)+0.00%-1.18%+11.37%-12.55%-12.55%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NGNE · 1,344,307 shares · as of Mar 26, 2026
0336,915673,8301,010,7441,347,65920252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 6 buys / 1 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NGNE
NEUROGENE INC.
SALE10b5-1
10b5-1 plan
3,352$22.07$74.0K1,344,307Mar 26, 2026Mar 30, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
155,100155,100Feb 20, 2026Feb 24, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
25,9001,347,659Feb 20, 2026Feb 24, 2026View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
23,9001,274,259Mar 26, 2025Mar 28, 2025View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
143,500143,500Mar 26, 2025Mar 28, 2025View →
NGNE
NEUROGENE INC.
PURCHASE
Chief Executive Officer
47,500$20.40$969.0K1,297,859Nov 22, 2024Nov 25, 2024View →
NGNE
NEUROGENE INC.
PURCHASEGRANT
Stock grant
93,28293,282Mar 13, 2024Mar 14, 2024View →
Other insiders · NGNE
Loading peer insiders…
About this filer
CIK 0001606302
ROLE
Chief Executive Officer
PRIMARY
NGNE
COMPANIES
1
ACTIVE SINCE
Mar 2024
MARKETPEEL · /INSIDER/0001606302DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback